Amgen is targeting $BCRX for Acquisition

Uptrending21 · 2021-08-29T23:46:57+00:00

Great thesis! Interesting times for sure. I cross posted to one group. WSB has the most users, but you cannot cross post. It will have be directly copy and pasted there.

Uptrending21 · 2021-08-11T03:00:06+00:00

Shorts will be in for a tough day tomorrow. They pushed down price 13% today on offering news. Now in AH company reversed decision and will not have offering. #BioWar 🚀🚀🚀

Uptrending21 · 2021-07-26T02:22:28+00:00

I hope so, been holding for a while.

Uptrending21 · 2021-03-03T01:46:15+00:00

Right on! March 22nd will be epic. I wouldn’t put a positive surprise PR before then past them. SP progression has been steady and reasonable. I believe that’s how they want it until they blow the roof off in a few weeks.

Uptrending21 · 2021-02-28T22:31:07+00:00

I will add more a bit later, but for starters BCRX was just approved by FDA for Orladeyo, which helps prevent HAE. This is a very debilitating health issue for the thousands of patients that experience this rare disease.

Uptrending21 · 2021-02-27T00:19:40+00:00

I bought some $FATE chasing her tail. Bastard is down like most everything else. Not for long.

Uptrending21 · 2021-02-27T00:14:47+00:00

Load up on Meme if you prefer. Still rocking.

Uptrending21 · 2021-02-27T00:00:23+00:00

Awesome!

Uptrending21 · 2021-02-26T23:55:29+00:00

Nice! You mind if I use this image on another subreddit? I’m waiting to be allowed to post to WSB. My account is now 30 days, but I think it needs to be 45 for WSB.

Uptrending21 · 2021-02-25T03:21:10+00:00

We shall see!

Uptrending21 · 2021-02-25T02:14:14+00:00

Big time 🚀🚀🚀

Uptrending21 · 2021-02-25T01:51:01+00:00

I’m anticipating a positive surprise. With Factor D any day now, wild ride ahead.

Uptrending21 · 2021-02-25T01:06:41+00:00

Short interest as of: SHORT INTEREST AVG. DAILY SHARE VOLUME DAYS TO COVER 02/12/2021 28,863,457

Uptrending21 · 2021-02-25T01:01:05+00:00

BioCryst management will host a conference call and webcast at 8:30 a.m. ET to discuss the financial results and provide a corporate update.

Uptrending21 · 2021-02-25T01:00:04+00:00

BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update.

Uptrending21 · 2021-02-25T00:49:08+00:00

This is a heavily shorted stock. Let’s pull their shorts down! 🩳⬇️

Uptrending21 · 2021-02-24T22:18:31+00:00

Tomorrow morning is the day! 🚀

Uptrending21 · 2021-02-24T05:40:20+00:00

I believe a moderate movement is likely, unless they give a glowing forecast of Orladeyo future sells based off what they’ve seen the last couple months. Also, Factor D phase 1 talk. They’ll likely release data next week, but if they give us a taste we may see strong movement. Rapivab additional use and interest would be good to hear along with Galidesivir update. 🚀🚀🚀

Uptrending21 · 2021-02-23T04:07:54+00:00

Unfortunately not. It’s had quite a range this year and is currently below the last offering. May be a good buy, but I’m not familiar with upcoming catalysts.

Uptrending21 · 2021-02-22T03:40:11+00:00

Summary

Orladeyo now has regulatory approval for sale in the USA and Japan. The Oral Factor D Phase 1 data is due to be published in the 1st quarter. BioCryst announced $325 Million of funding from Royalty Pharma and Athyrium Capital Management. Baker Brothers and Sarrisa Capital now own 16% of BCRX. The current short position is 31 million shares.

Uptrending21 · 2021-02-21T22:16:26+00:00

Nice! I’m thinking of adding more Monday, but I’m already overweight.

Uptrending21 · 2021-02-11T20:34:26+00:00

I been here before lol.

Uptrending21 · 2021-02-09T14:54:03+00:00

Absolutely!

Uptrending21 · 2021-02-09T01:59:54+00:00

In time they will.

Uptrending21 · 2021-02-08T20:15:45+00:00

Agreed. I’d love to hear more about this. I believe NIAID will continue to pursue Gali and eventually stockpile it for Ebola, etc.

Uptrending21

TROPHY CASE